Introduction
Surgical excision of the involved part of the liver represents the only curative treatment for hepatocellular carcinoma (HCC). The liver is the most common site of recurrence following resection of the tumor and intrahepatic recurrence often develops soon after partial hepatectomy (PH). It is still unclear if this is due to preexisting microscopic disease, surgical manipulation, or the spread of metastasis through the portal vein from the primary tumor. Multicentric HCC growth may also cause intrahepatic recurrence. It is thought that PH stimulates the growth of microscopic tumors and a number of experimental studies suggest that the growth of residual tumor cells may be enhanced by partial hepatectomy. [1] [2] [3] HCC is characterized by hypervascularity and arterial tumor stain on angiography, and tumor angiogenesis is considered indispensable for HCC growth. [4] [5] [6] Therefore, the inhibition of tumor angiogenesis may result in the suppression of HCC growth. TNP-470, a new synthetic analog of fumagillin, isolated from Aspergillus fumigatus, is known to inhibit angiogenesis by selectively inhibiting DNA synthesis in endothelial cells. 7, 8 TNP-470 inhibits liver metastasis in several experimental models. [9] [10] [11] [12] [13] For example, Tanaka et al. reported that TNP-470 prevents liver metastases of VX2 carcinoma after 45% PH in rabbits. 12 However, whether TNP-470 can suppress accelerated HCC growth in the regenerating liver is unknown. The purpose of this study was to investigate the suppressive effect of TNP-470 on accelerated HCC growth in the regenerating liver, in a rat 70% PH model.
One of the problems associated with the anticancer agents administered after hepatectomy is that they inhibit DNA synthesis of the hepatocytes and retard liver regeneration.
14 On the other hand, the side effects of angiogenesis inhibitor are relatively less severe than those of anticancer agents. Therefore, we also examined whether TNP-470 retards liver regeneration.
Materials and Methods

Materials
The angiogenesis inhibitor TNP-470 was provided by Takeda Chemical Industries (Osaka, Japan). TNP-470 was suspended in a vehicle of 3% ethanol plus 5% arabic gum/saline.
Animals
Male Donryu rats, weighing 150-190 g, purchased from Japan SLC (Hamamatsu, Japan), were used in this experiment.
Tumors
The rat ascites hepatoma AH-130 cell line was kindly donated by the Cell Resource Center for Biomedical Research, Institute of Development, Aging, and Cancer of Tohoku University (Japan), and was maintained by serial intraperitoneal implantation in Donryu rats at 7-day intervals. The ascites obtained on the 7th day was used in this experiment. The viability of AH-130 cells was confirmed by trypan blue exclusion and more than 95% viable cells were used. A suspension of AH-130 cells in Hank's balanced salt solution was prepared at a concentration of 5 ϫ 10 6 cells/ml just before injection.
Hepatic Metastasis Model
After giving ether anesthesia, the abdomen of each rat was opened by a midline incision and the liver was gently manipulated. A 0.2-ml aliquot of cell suspension containing 1 ϫ 10 6 AH-130 cells was injected slowly into the portal vein using a 27-gauge needle. Care was taken to prevent fluid leakage from the portal vein puncture site and gentle pressure was applied there for a few minutes after the injection to achieve hemostasis.
Hepatic Metastasis Model After Partial Hepatectomy
After giving ether anesthesia, the abdomen of each rat was opened by a midline incision and a 70% PH, including resection of the left and median lobe, was done according to the Higgins and Anderson methods. 15 After 70% PH, tumor implantation was performed as above.
Assessment of Microvessel Density (MVD)
To evaluate the MVD of tumors, tumor sections were immunohistochemically stained for factor VIII-related antigen (FVIIIRAg). First, the liver tumors were frozen in liquid nitrogen and tumor sections were prepared, deparaffinized, and incubated with rabbit polyclonal antibody against human FVIIIRag (Dako, Kyoto, Japan), using the ABC kit. The MVD of the tumors was determined under a light microscope at ϫ200 magnification. Five areas with the highest density of FVIIIRAg-positive staining were selected for counting. For each tissue sample, the MVD was expressed as the mean number of vessels per mm 2 .
Experimental Protocols Accelerated Tumor Growth in the Regenerating Liver
The rats were divided into a sham group (n ϭ 13), subjected to the hepatic metastasis model, and a PH group (n ϭ 14), subjected to the hepatic metastasis model after PH. All rats were killed by exsanguination from the abdominal aorta on day 14 and the number of foci on the surface of the liver, the liver weight, and the MVD of the tumors were examined.
Suppressive Effect of TNP-470 on Accelerated Tumor Growth in the Regenerating Liver
All rats were subjected to the hepatic metastasis model after PH. The rats were then divided into a control group (n ϭ 10), which received the vehicle only, and a treated group (n ϭ 11), which received TNP-470 at a dose of 10 mg/kg body weight, subcutaneously, every second day from 24 h after tumor implantation, seven times. All rats were killed by exsanguination from the abdominal aorta on the 14th day and the number of foci on the surface of the liver, the liver weight, and the MVD of the tumors were examined.
Effect on Liver Regeneration and Side Effects of TNP-470
All rats were given 70% PH. They were then divided into a vehicle group (n ϭ 8), which received the vehicle only, and a TNP group (n ϭ 8), which received TNP-470 at a dose of 10 mg/kg body weight, subcutaneously, every second day from 24 h after PH, three times. All rats were killed by exsanguination from the abdominal aorta on the 7th day, and their body weight was recorded. The liver was then excised and weighed. The blood was analyzed for the total bilirubin concentration (T-Bil), serum glutamic oxaloacetic transaminase (GOT), and serum glutamic pyruvic transaminase (GPT). T-Bil, GOT, and GPT were also examined in normal rats (normal group, n ϭ 12).
Statistical Analysis
Data are expressed as mean Ϯ standard deviation in the text and as mean Ϯ standard error in the graphs. If the hypothesis that the distributions of the two groups were the same could be made, Student's t-test was used for statistical analysis. If this hypothesis could not be made, Welch's t-test was used. Values of P Ͻ 0.05 were considered significant.
Results
Accelerated Tumor Growth in the Regenerating Liver
The number of foci on the surface of the liver was significantly higher in the PH group (376.6 Ϯ 308.7) than in the sham group (76.0 Ϯ 59.7) (P Ͻ 0.05) (Fig.  1a) . The liver tended to weigh more in the PH group (16.98 Ϯ 8.01 g) than in the sham group (13.58 Ϯ 1.42 g), but the difference was not significant (Fig. 1b) (Figs. 1c and 3 ). These results suggest that tumor angiogenesis and tumor growth were accelerated in the regenerating liver.
Suppressive Effect of TNP-470 on Tumor Growth in the Regenerating Liver
The number of foci on the surface of the liver was significantly less in the treated group (116.5 Ϯ 103.1) than in the control group (319.3 Ϯ 223.1) (P Ͻ 0.05) (Fig. 2a) (Figs. 2c and 4) . These results suggest that TNP-470 was able to suppress tumor angiogenesis and tumor growth in the regenerating liver.
We also tested two other doses of TNP-470 using the same methodology. At a TNP-470 dose of 3 mg/kg body weight, the number of foci on the surface of the liver tended to be less in the treated group (n ϭ 15) (259.3 Ϯ 181.7) than in the control group (n ϭ 13) (278.9 Ϯ 115.2), but the difference was not significant. At a TNP-470 dose of 30 mg/kg body weight, 11 rats (68.8%) in the treated group (n ϭ 16) died within 14 days, due to massive weight loss. At a TNP-470 dose of 10 mg/kg body weight, none of the rats in the treated group died.
Effects on Liver Regeneration and Side Effects of TNP-470
The effects of TNP-470 on liver regeneration are shown in Table 1 . The liver weight in the TNP group (11.07 Ϯ 0.80 g) was similar to that in the vehicle group (10.77 Ϯ Fig. 1. a The number of foci on the surface of the liver was significantly higher in the partial hepatectomy (PH) group than in the sham group (P Ͻ 0.05). b The liver tended to weigh more in the PH group than in the sham group, but the difference was not significant. c Microvessel density was significantly higher in the PH group than in the sham group (P Ͻ 0.05). These results suggest that tumor angiogenesis and tumor growth were accelerated in the regenerating liver. Data are expressed as mean Ϯ standard error in the graphs However, the liver weight was similar in the vehicle group and the TNP group 7 days after 70% PH. T-Bil, GOT, and GPT were not higher in the TNP group than in the vehicle group. These results indicate that our treatment dose of TNP-470 did not retard liver regeneration.
Discussion
Hepatocellular carcinoma is a typical hypervascular tumor, which is shown as positive arterial tumor staining on angiography. The feeder vessel of classical HCC is the hepatic artery and the intranodular vascular architecture of classical HCC can be characterized by massive arterial tumor angiogenesis and a lack of portal perfusion. 4 However, in adenomatous hyperplasia, which is considered a premalignant lesion, the feeding arterial blood flow is poor and portal perfusion is well maintained. 16 As small HCCs increase in size, the intranodular portal perfusion decreases and arterial tumor angiogenesis develops. 5 Some studies suggest that many HCCs may evolve from a highly differentiated HCC and transform into a less differentiated type. 17, 18 In this process of dedifferentiation of small HCCs, the intranodular portal perfusion decreases and arterial tumor angiogenesis develops. 5, 6, 19 A tumor with poor intranodular portal perfusion grows significantly faster than one with strong portal perfusion. It is thought that this increased arterial blood flow promotes faster tumor growth. Tanigawa et al. investigated the relationship between tumor vascua b c Fig. 2 . a The number of foci on the surface of the liver was significantly less in the treated group than in the control group (P Ͻ 0.05) b The liver tended to weigh less in the treated group than in the control group, but the difference was not significant. c Microvessel density was significantly less in the treated group than in the control group (P Ͻ 0.05). These results suggest that TNP-470 was able to suppress tumor angiogenesis and tumor growth in the regenerating liver. Data are expressed as mean Ϯ standard error in the graphs Values are mean Ϯ SD T-Bil, total bilirubin; GOT, serum glutamic oxaloacetic transaminase; GPT, serum glutamic pyruvic transaminase * P Ͻ 0.05 versus vehicle value larity (microvessel density, MVD) and the outcome of patients with HCC and found that a tumor diameter larger than 2 cm, poor differentiation, and portal invasion were significantly related to higher MVD. 20 Accordingly, tumor angiogenesis is considered indispensable for the growth of HCCs and therefore, inhibiting tumor angiogenesis could suppress HCC growth. Hepatectomy may stimulate the growth of microscopic tumors. A number of experimental studies have suggested that tumor growth may be enhanced by hepatectomy, [1] [2] [3] which was confirmed in the present study. We established an animal model that shows accelerated tumor growth in the regenerating liver, created by injecting-tumor cells into the portal vein after 70% PH.
The number of foci on the surface of the liver was significantly higher in the PH group than in the sham group (P Ͻ 0.05). Thus, this model can be used to demonstrate that microscopic residual tumors are enhanced by PH. The mechanism of enhanced tumor growth after PH has been examined by other researchers. Picardo et al. reported that changes in intrahepatic cytokinegrowth factor [transforming growth factor (TGF)-α, TGF-, basic fibroblast growth factor] activation may contribute to enhanced tumor growth after PH. 3 Hepatocyte growth factor (HGF) has been identified as the most potent mitogen for primary hepatocytes in liver regeneration and increases after PH. According to some studies, HGF has potent angiogenic activity, 21, 22 while others report that HGF induces tumor cell motility, invasion, and angiogenesis during tumor-stromal interaction. 23, 24 In contrast, HGF has been shown to inhibit the growth of HCC in vivo and in vitro. 25, 26 Whether HGF stimulates the tumor growth of HCC remains unclear. In the present study, the microvessel density was found to be significantly higher in the PH group than in the sham group (P Ͻ 0.05), suggesting that accelerated tumor growth in the regenerating liver may be implicated in tumor angiogenesis. To our knowledge, this is the first experimental study to show that HCC growth in the regenerating liver was accelerated by tumor angiogenesis.
We speculate that HGF, which increases after PH induces tumor angiogenesis, in turn stimulates tumor growth in the regenerating liver.
TNP-470, a new synthetic analog of fumagillin, isolated from Aspergillus fumigatus, is known to inhibit angiogenesis by inhibiting DNA synthesis selectively in endothelial cells. 7, 8 TNP-470 inhibits liver metastasis in several experimental models.
9-13 Xia et al. reported the inhibitory effect of TNP-470 on tumor growth and metastasis in nude mice bearing human HCC, 13 but their in vitro study revealed that purified hepatoma cells were insensitive to TNP-470. Tanaka et al. reported that TNP-470 prevents liver metastases of VX2 carcinoma after 45% PH in rabbits. 12 We established more accelerated tumor growth in the regenerating liver, using a rat 70% PH model. The number of foci and the microvessel density were significantly less in the treated group than in the control group (P Ͻ 0.05) in this study. Our findings showed that TNP-470 can suppress tumor angiogenesis and accelerated HCC growth in the regenerating liver, at a dose of 10 mg/kg, administered subcutaneously every second day. At a dose of 3 mg/kg body weight, the suppressive effect on tumor growth was very limited.
Unfortunately, as the TNP-470 dose increases, so do the side effects. In several studies on the effects of TNP-470 on liver metastasis models, TNP-470 was administered at a dose of 15-30 mg/kg body weight subcutaneously every other day. [9] [10] [11] 13 However, in our model, when TNP-470 was administered at a dose of 30 mg/kg body weight, two thirds of the treated group died within 14 days, due to massive weight loss. Conversely, at a dose of 10 mg/kg body weight, none of the rats in the treated group died. The clinical application of TNP-470 may be limited by its side effects, such as body weight loss. Identification, then prevention of the mechanism by which TNP-470 induces body weight loss, would render TNP-470 a more useful agent, and one that could even be administered at a higher dose.
Alternative agents have been investigated for their effectiveness against tumor growth following PH. [27] [28] [29] Mizutani et al. reported the suppressive effect of 5-fluorouracil (5-FU) or mitomycin C on liver metastasis after PH. 27 However, anticancer agents, such as 5-FU or similar drugs, inhibit DNA synthesis of hepatocytes and retard liver regeneration, 14 suggesting that adjuvant chemotherapy following PH should not be performed until liver regeneration is almost complete.
Tanaka et al. reported that TNP-470 did not impair liver regeneration, 12 which they evaluated by the liver weight, bromodeoxyuridine (BrdU) labeling index, TBil, GOT, and GPT, 14 days after 45% partial hepatectomy in a rabbit model. The best model for studying liver regeneration is that introduced by Higgins and Anderson, involving a simple operation in which two thirds of the liver of a rat is removed. 15 The residual lobes enlarge to make up for the mass of the removed lobes within 7-10 days. 15, 30, 31 This model of 70% hepatic resection in rats has been widely used to investigate hepatic regeneration. 30, 31 In the present study, 7 days after 70% PH using a rat model, the liver weight was similar in the TNP and vehicle groups, and the T-Bil, GOT, and GPT were not higher in the TNP group than in the vehicle group. These findings suggest that TNP-470 does not retard liver regeneration at a dose of 10 mg/kg body weight, administered subcutaneously, every second day. After 70% PH, the regeneration of cell populations within the remnant liver initiate hepatocyte growth, with peak DNA synthesis between 24 and 48 h, followed in succession by peak DNA synthesis of biliary epithelial at 36-48 h, Kupffer and stellate cells at 48 h, and finally the sinusoidal endothelial cells at 96 h. 30, 32 After hepatocyte proliferation has subsided, by about 72 h postresection, single-cell wide plates of hepatocytes have grown to avascular clusters of 10-12 hepatocytes. 33 The proliferation and infiltration of avascular clusters of hepatocytes by the surrounding endothelial cells and the subsequent re-establishment of normal vascular architecture within the liver provides an exquisitely timed, controlled model of physiological angiogenesis. [32] [33] [34] Therefore, the angiogenesis of liver regeneration might be induced during a later phase. According to Yoshitoshi et al., after PH the number of hepatocytes increases, but the glisson does not. 35 We speculate that this could be why TNP-470 did not affect liver regeneration.
Microscopic residual HCC can develop rapidly in the regenerating liver. Consequently, we believe that the inhibition of angiogenesis during liver regeneration could be a potent treatment to suppress HCC growth following PH. In conclusion, the angiogenesis inhibitor TNP-470 can suppress HCC growth after PH, without retarding liver regeneration.
